Closing Gaps in STI Care Through Molecular Point-of-Care Testing
Molecular point-of-care testing has the potential to substantially mitigate the impact of sexually transmitted infections (STIs) on personal and public health. Listen in as Jeffrey D. Klausner, MD, MPH, explores how proper use of rapid point-of-care testing could also hold the key to limiting development of antimicrobial resistance.
Decera Clinical Education Infectious Disease Podcast · Jeffrey D. Klausner MD MPH
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Molecular point-of-care testing has the potential to substantially mitigate the impact of sexually transmitted infections (STIs) on personal and public health. Listen in to learn how it may even limit the development of antimicrobial resistance. Topics covered include:
- CDC and US Preventive Services Task Force STI screening recommendations
- Whether or not laboratory-based STI tests contribute to increasing antibiotic resistance
- Role of point-of-care testing and strategies for implementation
Presenter:
Jeffrey D. Klausner, MD, MPH
Clinical Professor of Medicine
Population and Public Health Sciences Lead
Infectious Diseases Epidemiology and Applies Studies (I.D.E.A.S.) Initiative
Keck School of Medicine of the University of Southern California
Los Angeles, California
Link to full program:
https://bit.ly/4nS7rYE
Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.